The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...
Zacks.com on MSN18h
FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for UrticariaSanofi SNY and partner Regeneron REGN announced that the FDA has accepted their resubmitted supplemental biologics license ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback